Bharat Immunological & Biologicals Corporation Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Mar ' 21

Sales

-

36.96

39.47

38.92

40.82

Operating profit

-9.00

-7.33

-2.53

-2.45

-17.00

Interest

3.81

3.32

3.21

2.38

2.52

Gross profit

-12.55

-10.19

-5.10

-4.37

-17.40

EPS (Rs)

-2.20

-1.87

-0.31

-1.72

-3.12

Other income

0.27

0.46

0.64

0.47

2.12

Stock adjustment

-

5.95

4.48

-4.03

24.32

Raw material

-

26.52

24.34

34.84

19.83

Power and fuel

-

-

-

-

-

Employee expenses

7.88

7.90

7.96

5.89

9.39

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

1.13

3.92

5.22

4.67

4.28

Provisions made

-

-

-

-

-

Depreciation

0.07

0.07

0.10

0.12

0.12

Taxation

-3.11

-2.18

-3.88

2.95

-4.06

Net profit / loss

-9.51

-8.08

-1.32

-7.43

-13.46

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

43.18

43.18

43.18

43.18

43.18

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-

-19.83

-6.41

-6.30

-41.65

GPM (%)

-

-27.23

-12.73

-11.10

-40.52

NPM (%)

-

-21.59

-3.29

-18.87

-31.35